Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Agonist Luteal Support in FET
NCT02620124Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- May 2013
- Primary completion
- Apr 2015
- Modality
- Peptides, Small Molecules
01
Overview
Phase 4, randomised, open-label trial of triptorelin in infertility (4 arms), sponsored by Turku University Hospital. Primary endpoints: Pregnancy rate at 5 weeks, Implantation rate at 5 weeks and 1 more. Started May 2013; status: completed.
02
Drugs
triptorelin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02620124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02620124.